MedTrace Logo

Short-term Behavior Change With Pedal Desk Installation

NCT02109432 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2019-03-29

Study results available
· View outcomes & findings →

Summary

The purpose of this investigation is to evaluate participant use of a dedicated office pedal desk with and without behavioral support.

Conditions

  • Physical Activity in the Workplace

Interventions

BEHAVIORAL

Self-Directed Pedal Desk

participants will have a pedal desk installed in their office and will have access to their daily recorded data but will not have any other form of feedback or goal-setting

BEHAVIORAL

Facilitated Pedal Desk

participants are provided with their daily recorded pedal desk data and additional daily behavioral support from an interventionist (e.g., feedback and goal-setting) to increase their use of the pedal desk by an individually negotiated and agreed upon amount

BEHAVIORAL

Facilitated Pedal Desk with Pedometer

participants will be provided with their daily recorded pedal desk and step count data and additional daily behavioral support from an interventionist (e.g., feedback and goal-setting) to increase their use of the pedal desk by an individually negotiated and agreed upon amount and increase their step count by 3,000 steps/day compared to baseline.

Sponsors & Collaborators

  • Pennington Biomedical Research Center

    lead OTHER

Principal Investigators

  • Corby K Martin, PhD · Pennington Biomedical Research Center

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02109432 on ClinicalTrials.gov